NUCRYST Pharmaceuticals Corp. - Annual General Meeting of Shareholders



    
                            Thursday, May 3, 2007
                                 Kellogg Room
                       Hilton Boston Financial District
                                 89 Broad St.
                                 Boston, MA
                               10:00 a.m. EDT
    

    CALGARY, April 5 /CNW/ - NUCRYST Pharmaceuticals Corp. will hold its
Annual General Meeting of Shareholders and Investor Briefing on Thursday,
May 3, 2007 at 10:00 a.m. EDT. The meeting will be held at the Hilton Boston
Financial District, Kellogg Room, 89 Broad Street in Boston. An agenda has
been posted on the NUCRYST website, www.nucryst.com.
    Both the meeting and investor briefing will be webcast live at
www.nucryst.com. An audio file of the webcast will be archived and posted on
the NUCRYST website.

    NUCRYST Pharmaceuticals (NASDAQ:   NCST; TSX: NCS) develops, manufactures
and commercializes medical products that fight infection and inflammation
using its patented atomically disordered nanocrystalline silver technology.
Smith & Nephew plc sell a range of advanced wound care products under their
Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST's
SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also
developing pharmaceutical products to address medical conditions that are
characterized by both infection and inflammation. The Company has developed
its proprietary nanocrystalline silver in a powder form for use as an active
pharmaceutical ingredient, referred to as NPI 32101.
    A more detailed discussion of NUCRYST's 2006 year end results can be
found in the 2006 Consolidated Financial Statements and Management's
Discussion and Analysis, which are available at www.sec.gov and www.sedar.com
and in NUCRYST's 2006 Annual Report on Form 10-K, which will be available on
the same websites. NUCRYST filings are also available at
www.nucryst.com/Regulatory_Filings.htm.

    %SEDAR: 00023031E




For further information:

For further information: Gillian McArdle, (416) 504-8464,
info@nucryst.com

Organization Profile

NUCRYST PHARMACEUTICALS CORP.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890